These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Menopause and stroke and the effects of hormonal therapy. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [TBL] [Abstract][Full Text] [Related]
5. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Vitale C; Miceli M; Rosano GM Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667 [TBL] [Abstract][Full Text] [Related]
6. Estrogens, lipids, and heart disease. Barrett-Connor E; Miller V Clin Geriatr Med; 1993 Feb; 9(1):57-67. PubMed ID: 8443740 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy and heart failure in women. Agabiti-Rosei E; Muiesan ML J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and the menopause: a global overview. Barrett-Connor E Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():6-14. PubMed ID: 8499961 [TBL] [Abstract][Full Text] [Related]
9. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. Jónsdóttir LS; Sigfússon N; Gudnason V; Sigvaldason H; Thorgeirsson G J Cardiovasc Risk; 2002 Apr; 9(2):67-76. PubMed ID: 12006913 [TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy of menopause, heart and blood vessels]. Kuttenn F; Gerson M Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629 [TBL] [Abstract][Full Text] [Related]
12. Hormones and cardiovascular health in women. ESHRE Capri Workshop Group Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276 [TBL] [Abstract][Full Text] [Related]
13. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause? Manson JE; Bassuk SS Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204 [TBL] [Abstract][Full Text] [Related]
14. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
15. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. Mohandas B; Mehta JL Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252 [TBL] [Abstract][Full Text] [Related]
18. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Ren J; Kelley RO Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173 [TBL] [Abstract][Full Text] [Related]
19. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related]